TITLE

The Future of HIV Prevention in the United States

AUTHOR(S)
Mermin, Jonathan; Fenton, Kevin A.
PUB. DATE
July 2012
SOURCE
JAMA: Journal of the American Medical Association;7/25/2012, Vol. 308 Issue 4, p347
SOURCE TYPE
Academic Journal
DOC. TYPE
Opinion
ABSTRACT
The article comments on the future of human immunodeficiency virus (HIV) prevention in the U.S. It states that in the U.S. 1.1 million people live with HIV, a 60 percent increase from 15 years ago. It states that the new strategy of the U.S. Centers for Disease Control and prevention (CDC) called "High Impact Prevention," involves prioritizing and implementing the optimal combination of cost-effective, scalable interventions based on current science.
ACCESSION #
78070215

 

Related Articles

  • CDC warns off anti-HIV drug.  // Healthcare Purchasing News;Feb2001, Vol. 25 Issue 2, p29 

    Stresses that U.S. doctors should not prescribe the HIV prevention drug Nevirapine to healthy hospital workers stuck by needles according to the U.S. Centers for Disease Control and Prevention. Health risks of Nevirapine; Number of reported cases where healthcare workers were infected with HIV...

  • To Screen or Not to Screen: Is That Really the Question? Branson, Bernard M. // Annals of Internal Medicine;12/5/2006, Vol. 145 Issue 11, p857 

    In this article, the author reflects on the cost-effectiveness of HIV screening. He compares the results of studies conducted by professor A. David Paltiel and colleagues and other HIV screening programs. He reveals the recommendation of HIV screening by the U.S. Centers for Disease Control and...

  • The Role of Cost-Effectiveness in U.S. Vaccination Policy. Kim, Jane J. // New England Journal of Medicine;11/10/2011, Vol. 365 Issue 19, p1760 

    The article examines the role of cost-effectiveness in the vaccination policy of the U.S. government. It presents several factors that drive vaccination policy, such as vaccine safety and potency, acceptability and societal value. It cites the Advisory Committee on Immunization Practices (ACIP),...

  • The ProVac International Working Group Begins its First Country Study of the Pilot Phase.  // Immunization Newsletter;Jun2012, Vol. 34 Issue 3, p8 

    The article presents information on the ProVac International Working Group (IWG), a project funded by the Bill & Melinda Gates Foundation, that aims to share ProVac Initiative tools and methodologies with nations other than the U.S. ProVac's tools and methods provide support for...

  • ADA-recommended interventions for diabetes control reviewed.  // PharmacoEconomics & Outcomes News;9/18/2010, Issue 612, p7 

    The article reprots that majority of the interventions for the prevention or control of diabetes mellitus suggested by the American Diabetes Association (ADA) are either cost saving, very cost-effective or cost-effective, according to researchers at the Centers for Disease Control and Prevention...

  • Cost-Effectiveness of Pooled Nucleic Acid Amplification Testing for Acute HIV Infection after Third-Generation HIV Antibody Screening and Rapid Testing in the United States: A Comparison of Three Public Health Settings. Hutchinson, Angela B.; Patel, Pragna; Sansom, Stephanie L.; Farnham, Paul G.; Sullivan, Timothy J.; Bennett, Berry; Kerndt, Peter R.; Bolan, Robert K.; Heffelfinger, James D.; Prabhu, Vimalanand S.; Branson, Bernard M. // PLoS Medicine;Sep2010, Vol. 7 Issue 9, p1 

    Background: Detection of acute HIV infection (AHI) with pooled nucleic acid amplification testing (NAAT) following HIV testing is feasible. However, cost-effectiveness analyses to guide policy around AHI screening are lacking; particularly after more sensitive third-generation antibody screening...

  • The GOLDEN BOY and the INVISIBLE ARMY. Lake, Thomas // Atlanta;Jun2010, Vol. 50 Issue 2, p64 

    The article offers information about the contribution of medical science in dealing influenza in the U.S. It states that science has managed various diseases including smallpox, polio, and malaria. The U.S. Centers for Disease Control & Prevention (CTC) has announced that every child under the...

  • The Magnitude of Key HIV Prevention Challenges in the United States: Implications for a New National HIV Prevention Plan. Holtgrave, David R.; McGuire, Jean Flatley; Milan Jr, Jesse // American Journal of Public Health;Jul2007, Vol. 97 Issue 7, p1163 

    The Centers for Disease Control and Prevention has undertaken an advisory process to update its national HIV prevention plan. We offer observations on the magnitude of HIV prevention challenges in the United States and reflect on how these challenges might influence the structure of a new HIV...

  • Evolution of HIV/AIDS Prevention Programs -- United States, 1981-2006.  // MMWR: Morbidity & Mortality Weekly Report;6/2/2006, Vol. 55 Issue 21, p597 

    Presents information on the evolution of HIV/AIDS prevention programs of the U.S. Centers for Disease Control and Prevention from 1981 to 2006. Details of various prevention activities in the country; Persons at high risk for contracting HIV infection; Overview of HIV counseling, testing, and...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics